Pharmacokinetics of mycophenolate and its glucuronidated metabolites in stable lung transplant recipients

被引：0
|
作者：
Partovi, N. [1 ]
Ting, L.
Ensom, M. H. H.
Riggs, W.
Levy, R. D. [2 ]
机构：
[1] Vancouver Gen Hosp, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 02期
关键词：
D O I：
10.1016/j.healun.2004.12.072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
360
引用
下载
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [31] Withdrawal of Mycophenolate Mofetil in stable renal transplant recipients.
    Meier-Kriesche, HU
    Kaza, H
    Thambuganipalle, R
    Vaghela, M
    Jacobs, HG
    Mulgaonkar, SP
    Friedman, GS
    Kaplan, B
    TRANSPLANTATION, 2000, 69 (08) : S132 - S132
  • [32] Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients
    Patel, Chirag G.
    Richman, Katherine
    Yang, Dongang
    Yan, Bingfang
    Gohh, Reginald Y.
    Akhlaghi, Fatemeh
    THERAPEUTIC DRUG MONITORING, 2007, 29 (06) : 735 - 742
  • [33] The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients
    Tang, Jiang-Tao
    de Winter, Brenda C.
    Hesselink, Dennis A.
    Sombogaard, Ferdi
    Wang, Lan-Lan
    van Gelder, Teun
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 812 - 822
  • [34] Cyclosporin changes the pharmacokinetics of mycophenolate mofetil in kidney transplant recipients.
    Gregoor, PJHS
    Hesse, CJ
    van der Mast, BJ
    IJzermans, JNM
    Weimar, W
    van Gelder, T
    KIDNEY INTERNATIONAL, 1999, 55 (03) : 1164 - 1164
  • [35] RAD in stable lung and heart/lung transplant recipients: Safety, tolerability, pharmacokinetics, and impact of cystic fibrosis
    Doyle, RL
    Hertz, MI
    Dunitz, JM
    Loyd, JE
    Stecenko, AA
    Wong, RL
    Chappell, KA
    Brazelton, T
    Kovarik, JM
    Appeldingmanse, S
    Dou, L
    Smith, HT
    Tudor, D
    Morris, RE
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (03): : 330 - 339
  • [36] Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients
    Merkel, U
    Lindner, S
    Vollandt, R
    Sperschneider, H
    Balogh, A
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (08) : 379 - 388
  • [37] Evaluation of valganciclovir pharmacokinetics in lung transplant recipients
    Kiser, Tyree H.
    Fish, Douglas N.
    Zamora, Martin R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (02): : 159 - 166
  • [38] Posaconazole Pharmacokinetics among Lung Transplant Recipients
    Clancy, C.
    Nguyen, M. H.
    Press, E.
    Shields, R. K.
    MYCOSES, 2015, 58 : 217 - 217
  • [39] A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients
    Seebacher, G
    Weigel, G
    Wolner, E
    Mallinger, R
    Grimm, M
    Laufer, G
    El Menyawi, I
    Griesmacher, A
    Müller, MM
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (04) : 409 - 415
  • [40] Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients
    Tania Claeys
    Maria Van Dyck
    Rita Van Damme-Lombaerts
    Pediatric Nephrology, 2010, 25 : 335 - 342
12345